Skip to main content
RH logo

RH · Rh

Track RH — free
$114.00 -2.99 (-2.56%)
Market Cap
$2.21B
Shares
18.93M
Volume · Oct 12 63.59K Avg daily vol (3M) 769.34K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$116.99 Open$114.00 Day$113.25–118.87 52W close$112.85–232.90 Avg vol 30d835K Short int5.3M · 28.0% float · 7.1d Short vol51% Last earningsSep 10, 2026 DataJan 2020–Oct 2026 Filing10-Q · Sep 10

Up next

Next earnings call
Dec 10, 2026 Est · unconfirmed · in 8 wks
filed Sep 10, 2026
call held Sep 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.45B
Trailing 12 months
Net income (TTM)
$111.51M
Trailing 12 months
Revenue growth YoY
+2.6%
Year over year
Operating margin
10.0%
Trailing 12 months
P / E (TTM)
20.8
Trailing earnings · reciprocal yield 4.8%
FCF yield
11.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.3%
Year over year · fewer shares
Price change (1Y)
-36.9%
Trailing year
Short interest
28.0%
Latest settlement · 7.1 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 14.8 · calm Equity put/call 0.56
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −26%
below
Price vs 50-day avg −20%
below
RSI (14) 32
neutral
MACD trend Positive
52-week position 3%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −13%
trailing
6-month return −18%
trailing
YTD return −35%
this year
Relative strength −28%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $146 › 200d $159 — 200d above 50d
Institutional flow Distributing
9 of 380 funds reported for Sep 30 · net -6.4K sh shares
Insider flow Distributing
Net -$132.0K over 90 days · 100% sells
Short interest Rising
27.96% of float · ▲ +5.8% MoM · 7.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
380 holders — mid 3-yr range
Squeeze score 69
elevated · 0–100
Fundamentals
Excellent
Revenue growth +25%
Y/Y
Gross margin 127%
contracting
EPS growth +74%
Y/Y
Free cash flow $252.4M
Valuation P/E 20.8
in line
Buyback $201.0M
remaining
Balance sheet $2.4B
net debt
Quant / Vol
risk profile
Very High
Volatility 60%
annualized · 1-yr
Max drawdown −52%
past year
ATR 4.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Sep 10, 2026
Fiscal Year 2026
Revenue Growth Maintained 5.5% – 7%
Jun 11, 2026 4.5% – 8% changed to Sep 10, 2026 5.5% – 7%
Adjusted EBITDA Margin Non-GAAP Raised 15% – 16.2%
Jun 11, 2026 14.2% – 16% changed to Sep 10, 2026 15% – 16.2%
Free Cash Flow, Asset Sales and Distribution of Equity Method In $300M – $400M
Adjusted capital expenditures Non-GAAP $240M – $260M
Gallery opening costs $48M
Third Quarter 2026
Revenue Growth 5% – 6%
Adjusted EBITDA Margin Non-GAAP 12.5% – 13.5%
Fourth Quarter 2026
Revenue Growth 16.1% – 21.2%
Adjusted EBITDA Margin Non-GAAP 19.7% – 22.9%
Fiscal Year 2027
Adjusted capital expenditures Non-GAAP $175M – $200M
Gallery opening costs $18M
Prior guidance period ended · from the 8-K filed Jun 11, 2026
Revenue Growth · second quarter 2026 0.5% – 2.5%
Adjusted EBITDA Margin · second quarter 2026 11.5% – 13%
Guided vs delivered · last 1 settled
Revenue fiscal 2022
guided $3.6B
$3.76B Beat +4.4%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−26% Bearish
Price vs 50-day avg
−20% Bearish
RSI (14)
32 Neutral
MACD trend
Positive Bullish
52-week position
3% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $146 › 200d $159 — 200d above 50d
Institutional flow Distributing
9 of 380 funds reported for Sep 30 · net -6.4K sh shares
Insider flow Distributing
Net -$132.0K over 90 days · 100% sells
Short interest Rising
27.96% of float · ▲ +5.8% MoM · 7.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
380 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $113 Now $117 · 3% Range high $233
vs 200-day avg -26% vs 50-day avg -20%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted capital expenditures non-GAAP 163.22M Six months ended August 1, 2026 —
adjusted capital expenditures (expected) non-GAAP $200M 2027 (high end of range) —
Adjusted diluted net income per share non-GAAP $0.81 Six months ended August 1, 2026 —
Adjusted EBITDA Margin non-GAAP 19.4% Q2 2026 —
Adjusted gross margin non-GAAP 45.1% Six months ended August 1, 2026 —
Adjusted gross profit non-GAAP 776.11M Six months ended August 1, 2026 —
Adjusted net income non-GAAP 15.96M Six months ended August 1, 2026 —
Adjusted operating margin non-GAAP 7.2% Six months ended August 1, 2026 —
Adjusted selling, general and administrative expenses non-GAAP 652.32M Six months ended August 1, 2026 —
Adjusted selling, general and administrative expenses margin non-GAAP 37.9% Six months ended August 1, 2026 —
Cash Generation non-GAAP $72.3M Q2 2026 —
design pipeline at RH London, The Gallery in Mayfair $7M first 8 weeks —
drag from International 450 half one of 2026 —
drag from International (expected) 340 full year 2026 —
Gallery opening costs $48M 2026 —
Gallery opening costs (expected) $18M 2027 —
Normalized Adjusted EBITDA non-GAAP $123.5M Q2 2026 —
GAAP → non-GAAP reconciliation
GAAP Adjusted EBITDA 178.55M
-55.09M IEEPA tariff refund benefit
= Normalized adjusted EBITDA 123.46M
Normalized Adjusted EBITDA Margin non-GAAP 13.4% Q2 2026 —
Segment adjusted operating income non-GAAP $110.88M Three months ended August 1, 2026 filing —
Trailing twelve months adjusted EBITDA non-GAAP 540.41M Trailing twelve months ended August 1, 2026 —
Adjusted net income (loss) non-GAAP -37.2M Three Months Ended May 2, 2026 filing —
Retail location count 90 Three Months Ended May 2, 2026 filing —
Total selling square footage 1.73M Three Months Ended May 2, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Retail — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RH
Rh
this stock
$2.21B -34.7% +24.5% 20.8 28.0%
WSM
Williams Sonoma Inc
$28.48B +35.4% +1.2% 24.8 4.6%
ULTA
Ulta Beauty, Inc.
$24.39B -5.7% +9.7% 20.8 5.7%
CASY
Caseys General Stores Inc
$23.89B +16.9% +10.2% 31.1 4.6%
BBY
Best Buy Co Inc
$18.25B +30.0% +0.4% 14.5 7.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
380
% held
134.3%
Reported
9 of 380
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
320
View
Short & Settlement
Short Interest Rising
Shares short
5.3M
Days to cover
7.1d
Change
+290.6K sh
View
Short Volume
Short vol %
51%
As of
Oct 9, 2026
Short Total
View
Fails to Deliver
FTD shares
53
Value
$7.1K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
45.0%
Week of
Sep 7, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$132.0K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Buy
Member
Maria Elvira Salazar
Amount
$15.0K–$50.0K
Traded
Mar 19, 2026
View
Financials
Financials
Revenue (FY)
$2.6B
Net income (FY)
$124.8M
EPS diluted
$6.31
View
Buybacks
Authorized
$2.5B
Remaining
$201.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 10, 2026
This year
11
View
Proposed Sales
Value
$132.0K
Shares
1.0K
Filed
Sep 22, 2026
View
Earnings & Events
Webcasts
Last webcast
Sep 10, 2026
View

Performance

5D 20D 120D MTD YTD
RH -2.9% -12.7% -18.0% -3.9% -34.7%
SPY +1.2% +1.9% +9.9% +2.1% +14.2%
vs SPY -4.0% -14.6% -27.9% -6.0% -48.9%

Capital returns

Buyback program · as of Aug 1, 2026
Authorized
$2.45B
Spent (derived)
$2.25B
Remaining
$201.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1528849 CUSIP 74967X103 13F (30d) 11 filings 11 filers Visit website Investor relations